Acerca de
Revise. Change. Controle. Colesterol
Revise. Change. Controle. Colesterol
![Two doctors and a nurse having a discussion](/-/media/Images/Health-Topics/Cholesterol/CCC-About-hero.jpg?h=611&iar=0&mw=960&w=960&sc_lang=es)
An estimated 126.9 million US adults are living with at least one type of cardiovascular disease (CVD)1, and by 2035, persons with CVD will account for nearly 45% of the adult US population.
The accumulation low-density lipoproteins (LDL-C) can lead to plaque deposits and atherosclerosis, increasing the risk for heart attack and stroke. Sadly, LDL-C is on the rise. A nivel mundial en el 2020, hubo 4.51 millones de muertes atribuibles a altos niveles de LDL-C, un aumento del 19% desde el 2010.
Latest Guideline Recommendations
Despite evidence promoting the efficacy of statin therapy for cholesterol management, longitudinal studies(link opens in new window)(link opens in new window)(link opens in new window)(link opens in new window)(link opens in new window)(link opens in new window) have confirmed that statin treatment rates were unchanged following the release of the 2013 ACC/AHA Guideline. The opportunity for a targeted blood cholesterol strategy gave rise to the most current ACC/AHA guideline, the 2018 Guideline on the Management of Blood Cholesterol(link opens in new window)(link opens in new window)(link opens in new window)(link opens in new window)(link opens in new window)(link opens in new window).
In the current guideline, new support for primary and secondary prevention of ASCVD was released that highlight the importance of identifying very-high risk atherosclerotic cardiovascular disease (ASCVD) patients, as well as intensification to non-statin agents such as ezetimibe and PCSK-9 inhibitors when clinically indicated. This model endeavors to provide clinicians with the algorithm-based tools to understand, treat, and control cholesterol for good.
Únase a nuestra iniciativa Revise. Change. Controle. Colesterol™
La AHA lanzó Check. Change. Controle. Colesterol para mejorar la identificación y el tratamiento del colesterol en Estado Unidos. Esta iniciativa nacional tiene como objetivo reducir la cantidad de estadounidenses que sufren de ataques cardíacos y accidentes cerebrovasculares. Para ello, insta a los consultorios médicos, a los proveedores y a los pacientes a que procuren detectar y traten este importante factor de riesgo.Revise. Change. Controle. Colesterol apoya a médicos y equipos de cuidado de la salud brindándoles acceso a las últimas investigaciones, herramientas y recursos para alcanzar y manteniendo las tasas de control de colesterol entre la población de pacientes adultos a los que atienden.
![HCP with laptop](/-/media/Images/Professional/Quality-Improvement/Outpatient-programs/475x475-laptop-registration.jpg?h=475&iar=0&mw=600&w=475&sc_lang=es)
¡Únase!
Revise. Change. Controle. Colesterol
Patrocinador
Amgen es un orgulloso promotor de la iniciativa Revise. Cambie. Controle. Colesterol™.